Positive results with SGLT2 inhibitor in patients with diabetic kidney disease across all levels of eGFR
This video was recorded at the ISN World Congress of Nephrology in Melbourne, Australia, on April 15, 2019.
Prof Carol Pollock, MD, is a nephrologist and Professor of Medicine at the University of Sydney School of Medicine, Sydney, Australia
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.